These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32010688)

  • 21. Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene.
    Andresen BS; Bross P; Vianey-Saban C; Divry P; Zabot MT; Roe CR; Nada MA; Byskov A; Kruse TA; Neve S; Kristiansen K; Knudsen I; Corydon MJ; Gregersen N
    Hum Mol Genet; 1996 Apr; 5(4):461-72. PubMed ID: 8845838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent rhabdomyolysis with adult onset associated with a mutation in the ACADVL gene.
    Antunes AP; Nogueira C; Rocha H; Vilarinho L; Evangelista T
    J Clin Neuromuscul Dis; 2013 Dec; 15(2):69-72. PubMed ID: 24263034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
    Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
    Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impairment of mitochondrial bioenergetics and permeability transition induction caused by major long-chain fatty acids accumulating in VLCAD deficiency in skeletal muscle as potential pathomechanisms of myopathy.
    Cecatto C; Amaral AU; Roginski AC; Castilho RF; Wajner M
    Toxicol In Vitro; 2020 Feb; 62():104665. PubMed ID: 31629068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD(-/-)) mice.
    Tucci S; Krogmann A; Herebian D; Spiekerkoetter U
    Mol Cell Pediatr; 2014 Dec; 1(1):5. PubMed ID: 26567099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and molecular heterogeneity in very-long-chain acyl-coenzyme A dehydrogenase deficiency.
    Pons R; Cavadini P; Baratta S; Invernizzi F; Lamantea E; Garavaglia B; Taroni F
    Pediatr Neurol; 2000 Feb; 22(2):98-105. PubMed ID: 10738914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
    Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
    Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very-long-chain acyl-CoA dehydrogenase subunit assembles to the dimer form on mitochondrial inner membrane.
    Souri M; Aoyama T; Hoganson G; Hashimoto T
    FEBS Lett; 1998 Apr; 426(2):187-90. PubMed ID: 9599005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolite accumulation in VLCAD deficiency markedly disrupts mitochondrial bioenergetics and Ca
    Cecatto C; Amaral AU; da Silva JC; Wajner A; Schimit MOV; da Silva LHR; Wajner SM; Zanatta Â; Castilho RF; Wajner M
    FEBS J; 2018 Apr; 285(8):1437-1455. PubMed ID: 29476646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation analysis of very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: identification and characterization of mutant VLCAD cDNAs from four patients.
    Souri M; Aoyama T; Orii K; Yamaguchi S; Hashimoto T
    Am J Hum Genet; 1996 Jan; 58(1):97-106. PubMed ID: 8554073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a Tandem Mass Spectrometry Method for Rapid Measurement of Medium- and Very-Long-Chain Acyl-CoA Dehydrogenase Activity in Fibroblasts.
    Bouvier D; Vianey-Saban C; Ruet S; Acquaviva C
    JIMD Rep; 2017; 35():71-78. PubMed ID: 27943070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature.
    Katz S; Landau Y; Pode-Shakked B; Pessach IM; Rubinshtein M; Anikster Y; Salem Y; Paret G
    Mol Genet Metab Rep; 2017 Mar; 10():5-7. PubMed ID: 27995075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma.
    Burrage LC; Miller MJ; Wong LJ; Kennedy AD; Sutton VR; Sun Q; Elsea SH; Graham BH
    J Pediatr; 2016 Feb; 169():208-13.e2. PubMed ID: 26602010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenase.
    Merritt JL; Matern D; Vockley J; Daniels J; Nguyen TV; Schowalter DB
    Mol Genet Metab; 2006 Aug; 88(4):351-8. PubMed ID: 16621643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
    Tucci S; Flögel U; Hermann S; Sturm M; Schäfers M; Spiekerkoetter U
    Biochim Biophys Acta; 2014 May; 1842(5):677-85. PubMed ID: 24530811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of two novel mutations in the hypoglycemic phenotype of very long chain acyl-CoA dehydrogenase deficiency.
    He G; Yang BZ; Roe DS; Teramoto R; Aleck K; Grebe TA; Roe CR; Ding JH
    Biochem Biophys Res Commun; 1999 Oct; 264(2):483-7. PubMed ID: 10529389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency.
    Yamaguchi S; Indo Y; Coates PM; Hashimoto T; Tanaka K
    Pediatr Res; 1993 Jul; 34(1):111-3. PubMed ID: 8356011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-generation sequencing identifies a homozygous mutation in ACADVL associated with pediatric familial dilated cardiomyopathy.
    Carlus SJ; Almuzaini IS; Karthikeyan M; Loganathan L; Al-Harbi GS; Abdallah AM; Al-Harbi KM
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1710-1721. PubMed ID: 30840296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the bidirectional promoter region between the human genes encoding VLCAD and PSD-95.
    Zhang LF; Ding JH; Yang BZ; He GC; Roe C
    Genomics; 2003 Dec; 82(6):660-8. PubMed ID: 14611808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.